Stephanie Gasking Clinical Oncology Society of Australia Annual Scientific Meeting 2026

Abstracts this author is presenting:

• Patient characteristics and treatment patterns of patients with advanced NSCLC harboring MET exon 14 (METex14) skipping enrolled in MOMENT disease registry — Wednesday Poster Session
• De novo and acquired MET amplification in patients with non-small cell lung cancer (NSCLC) treated with tepotinib: Results from a real-world data analysis in Australia — Wednesday Poster Session